AI compliance in pharma: where manual control breaks
Regulatory dossiers, specifications, batch records, and change logs live in dozens of files and email chains. While the volume is small, manual document control works: a specialist checks the revision against the registry entry and catches discrepancies by eye.
With hundreds of documents and weekly edits, such reconciliation runs into the limits of a particular person's attention and workload.
Change traceability suffers first. An edit was made in a working copy, but the registry still has the previous wording; who changed the clause and why is reconstructed from correspondence.
When an inspector requests the history of a specific record, it is assembled manually, and every missed step turns into a separate finding.
Errors in the registry accumulate unnoticed: a shifted date, an old revision of an instruction, a batch number from a canceled protocol.
Individually, these are minor; together, they create a discrepancy between what is declared to the regulator and what actually happens in production. It usually surfaces during an inspection, when documents are already signed and some batches have been shipped.
AI compliance in pharma here addresses not the task of "replacing the specialist" but the task of continuous reconciliation: the system parses incoming documents, matches them against master data, flags discrepancies, and keeps a decision log indicating the source.
Regulatory requirements remain the same — what changes is when a deviation becomes visible: not a week before the audit, but immediately upon occurrence. Below, we break down how this works.
What automatic data and quality control changes
Automated control delivers five measurable effects, and each is verified already at the implementation stage.
The speed of data verification changes radically: a sample for an inspection or internal audit request is assembled not over hours of manual consolidation but in minutes, because records from several accounting systems are brought into one loop with a change log.
The share of routine operations removed from employees is calculated by the number of checks the system closes on its own — ranges, expiration dates, field completeness, consistency of the batch number and the release record.
Rule-based validation at entry
Rules are applied at the moment of recording, not at the end of the reporting period: a record with incomplete or contradictory attributes does not pass further, receives a deviation status, and remains in a traceable form.
This changes the class of missed violations — errors that previously surfaced during reconciliation are cut off at entry, not after release.
Traceability rests on the fact that each record stores the source, time, and author of the change, so the chain from raw materials to the finished batch is reconstructed without manual searching through email and spreadsheets.
Risk-based prioritization of deviations
A deviation is weighted by risk: a critical one blocks batch movement and immediately goes to the responsible person, while a secondary one joins the queue and does not distract specialists.
Response speed is measured by the time from registration to decision, and workload is redistributed — people handle disputed cases rather than a continuous stream of same-type records.
The volume of the open registry stops growing: resolved deviations are archived together with edit trails, and even at peak load the queue remains manageable rather than turning into a dumping ground.
Deployment options: cloud, on-premises, hybrid
The hosting mode determines which data can leave the customer's perimeter at all and what will have to be proven to an inspector.
The options differ not only in infrastructure but also in how models are updated and where the decision log is kept — these are the main points of comparison between vendors.
| Option | When it fits | Limitations |
|---|---|---|
| On-premises | Patient personal data, study protocols, trade secrets | Requires your own capacity; model updates follow your schedule, with a delay relative to the external perimeter |
| Hybrid mode | Sensitive records stay inside; analytics runs on anonymized samples | Requires an anonymization layer and control over the list of fields that leave the perimeter |
| Cloud perimeter | Public documents, reference data, reports without personal data | Integration with accounting systems only via external interfaces; sensitive data must not be placed there |
On-premises for sensitive data
The entire chain remains inside the perimeter: storage, model, decision log. Integration with accounting systems and laboratory information systems goes through internal channels, without reaching the external network. The trade-off is that you accept updates yourself, after validation on historical data.
Hybrid mode: what is stored where
Locally — source records and personal data; in the external perimeter — only anonymized samples for retraining and review of disputed cases. Fields go outside strictly according to the list; the rest is cut off at entry.
The decision log remains inside, so every decision has a full trail — what was input, what the model returned, who confirmed it.
Implementation stages: from process assessment to handover
The project proceeds in six stages: from describing manual checks to handing the system over to the customer's team. Each stage closes with an artifact by which the result can be verified — "we configured it and everything works" is not accepted here.
- Process assessment. We go through areas with manual checking — quality dossiers, registration materials, pharmacovigilance, labeling — and record where the error occurs and how long the cycle takes.
- Data map. We describe the sources: accounting systems, scans, email, archive — field format, owners, change frequency. What will have to be cleaned up before configuration is already visible here.
- Configuration of rules and models. We translate regulatory requirements into formal rules, and the model into document parsing: it highlights fragments and discrepancies, and the rule decides what to do with them.
- Solution validation. We compare the system's findings with specialists' conclusions on closed periods.
- Deviation review procedure. We describe who reviews a disputed case and within what timeframe, and how the rule is corrected afterward.
- Employee training and handover.
Validation on historical data
We run the system on closed periods with a known outcome and calculate the share of discrepancies it finds on its own and the share it sends to a human.
We tune the threshold after which a document goes to manual review so that critical nonconformities are not missed and the flow of excess alerts does not grow.
Training the customer's team
Handover is not recording an instruction. Two or three employees go from processing the document queue to independently editing rules in the test environment. By project closure, they add a new document type and read the decision log without our involvement.
Implementation artifacts: diagrams, procedures, data model
The implementation of an AI compliance automation system in pharma ends not with a model but with a set of artifacts by which the system can be operated, audited, and handed over to another team. What remains in hand:
- documented validation rules: what counts as compliance, which discrepancies block a batch, and which go to manual review;
- data flow diagram — from the record source to decision storage and export to external systems;
- data model with field definitions and relationships between batch, series, document, and system decision;
- access policies and user roles — separation of rights by areas of responsibility;
- deviation review procedure with responsibility boundaries and timeframes;
- instructions for shift personnel: how to confirm a decision, what to do in case of failure, where to escalate;
- change log — edits to rules, reference data, and rights are stored as versions; rollback to a previous revision is possible;
- development plan: which checks and data sources are connected in the next step.
Access policies and user roles
Rights are granted in groups on the principle of least privilege: a shift operator sees the validation queue and confirms decisions, a process engineer edits rules, an auditor reads history without the right to change it.
When an employee changes, access is changed with one action rather than by revising dozens of accounts.
Deviation review procedure
The procedure specifies what the system flags as a deviation, within what time it is reviewed, who makes the final decision, and how it enters the log.
This removes the main risk of automation: when the model and the specialist disagree, it is known in advance whose decision is final.
Case study: audit preparation cycle in pharma was reduced
The implementation case is an operating dosage form manufacturing site, where audit preparation each time ran into manual collection of evidence.
Data on batches, deviations, personnel training, and document versions lived in several accounting systems, and people had to consolidate it.
How it was before implementation
The sample was assembled manually: a quality engineer went through logs, exported records from accounting systems, including Veeva Vault, and consolidated them into one table.
Preparation took 12–15 working days, and some data became outdated by the time of submission and required re-reconciliation. Repeat findings concerned the same items: a late deviation record, a missing signature, a document version mismatch.
What changed after system handover
Validation rules were moved into machine form: the system checks document versions, signature dates, and completeness of records for each batch and assembles the audit package itself.
The sample is prepared in one working day instead of two weeks — the engineer reviews only flagged discrepancies.
About 85% of routine checks are closed automatically, audit preparation time was reduced from six weeks to 9–10 days, and repeat findings on the same items went from six to one or two per cycle.
The system was handed over together with the rule change procedure: when internal procedures are updated, an analyst adds a check in a day without rewriting the logic. Before-and-after metrics were taken at the same site and on the same audit types, so the comparison is valid.
How rules and machine learning models differ
Hard rules are deterministic checks: mandatory attributes, allowable ranges, license validity, format matching. They provide explainability by construction: the log retains the specific rule that fired and its version.
Where data is structured and the requirement is formulated unambiguously, a model is not needed — it would only add unpredictability.
Rules break down on variable data: free-form descriptions, scans, different wording of the same thing in documents from different departments. Each exception forces another condition to be added, the number of templates grows, and with it come false positives and review time. When alerts become too numerous, employees stop trusting them, and some violations go unnoticed.
The model generalizes by features and is resistant to paraphrasing, but here it is not enough to train it — the decision must be explained.
We show which text fragments or fields influenced the conclusion and set the threshold so that disputed cases go to a human for review rather than being rejected automatically.
Version control applies equally to both approaches. Editing a rule or retraining a model is a new version with a log: what was changed, on what data, how the false positive rate shifted. This makes it possible to reconstruct the logic of any past decision during an audit.
Therefore, in pharma the solution is almost always combined: rules hold the framework and mandatory checks, the model covers the variable part, and the link between them determines what goes to a human.
We calculate the choice of approach from the share of cases that rules close without exceptions — that is what shows where a model is really needed.
Concerns about integration, access, and false positives
Before launch, the customer checks not the quality of the model but how the solution will fit into the current perimeter: whether accounting will have to be rewritten, who will get access to sensitive data, and what will happen in a disputed case. Below are the questions asked first.
Does the solution break existing systems?
No — it integrates into them. Exchange with accounting systems, reference data, and the archive goes through standard interfaces; data is not duplicated, and reconciliation relies on the primary source.
An area that still runs on paper is accepted via scans and printed forms: fields are extracted and checked against the reference, and discrepancies are flagged for a specialist.
How are rights separated?
Roles are inherited from the corporate directory rather than created manually. Visibility is limited by department and document type; every action goes into the log linked to the user and rule version — the validation path is reconstructed step by step.
What does the system do with disputed cases?
It does not issue a verdict but raises a flag with a list of indicators: dosage mismatch, missing signature, expired date. A specialist makes the decision, and the labeling of disputed cases goes into retraining — the false positive rate falls from iteration to iteration.
How does the solution evolve after launch?
Rules and models are versioned separately, so a new document type is added without rebuilding the entire logic. Metrics — share of checks closed automatically, accuracy, share of flags — are displayed on a dashboard: they show where to adjust the sensitivity threshold.
Let's discuss your task and come back with an implementation plan
To make the review substantive, describe how validation is currently organized: which documents and data are involved, at what step a specialist is brought in, where items are most often returned for revision, and how many manual operations are required per preparation cycle.
This is enough to estimate the scope of work for your product range rather than for a generic showcase. We will analyze the current process, determine which checks we move to automation and which we deliberately leave to humans, and come back with an implementation plan.
- scope boundaries: what we cover in the first stage, what we leave outside the perimeter, and why;
- scope estimate: how many document and rule types are affected, and what timeline results from your dossier structure;
- project stages: collection of validation rules, a prototype on your sample, a production perimeter with a change log and access separation;
- integration scheme with the systems where the data already lives — without manually moving files between storages;
- traceability of findings: for each result, the source, applied rule, and the person who confirmed it are visible;
- solution handover: configurations, validation procedure, specialist instructions, and team training;
- measurable indicators: share of fields checked automatically, time to prepare the package, number of findings during repeat review.
Describe the task and bottlenecks of the current process — we will come back with an estimate, stages, and the scope of solution handover.